Recent Blog Posts

View Post: Study shows modest improvement in advanced lung cancer overall ...
4 hours ago by BJS  
Researchers performed an analysis of over 100000 patients with stage IV non-small cell lung cancer (NSCLC) identified through the SEER database to evaluate trends in survival between 1990 and 2005 to assess the true impact of recent ...
View Blog: Science Blog - Science news straight from... - http://www.scienceblog.com/cms/frontpage1

---

View Post: Prognostic Factors for Resected Non-Small Cell Lung Cancer with ...
27 Nov 2009 by Moretti, L., Yu, DS, Chen, H., Carbone,...  
For non-small cell lung cancer (NSCLC) patients with pN2 status, the use of postoperative radiotherapy (PORT) remains controversial. Here, we investigated the association between different clinicopathological features and postoperative ...
View Blog: The Oncologist current issue - http://theoncologist.alphamedpress.org/

---

View Post: NICE issues guidance on topotecan for relapsed small cell lung ...
25 Nov 2009
NICE has published guidance on the use of topotecan for small cell lung cancer (SCLC), which recommends oral topotecan as an option only for people with relapsed SCLC for whom: • re-treatment with the first-line regimen is not ...
View Blog: NeLM - Guidelines - http://www.nelm.nhs.uk/en/NeLM-Area/Evidence/Guidelines/

---

View Post: How Non-Small Cell Lung Cancer Is Treated
Lung Cancer Info
18 Nov 2009 by Brad Johansine   ...
View Blog: http://www.lung-cancer-info.com/

---

View Post: Small cell Lung Cancer Risk Factor
24 Nov 2009 by Nilum  
Small cell Lung Cancer Risk Factor. Tuesday, November 24, 2009. Lung Cancer be torn down into two types; baby corpuscle lung blight (SCLC) and non-small corpuscle lung cancer. SCLC accounts for about 20% of all lung cancers. ...
View Blog: Health Care Information

---

View Post: Improving Lung Cancer Prognosis
asbestos lung cancer disease
14 hours ago by hp860   ...
View Blog: http://diseaseasbestoslungcancer.blogspot.com/

---

View Post: NICE costing statement on implementing guidance on topotecan for ...
25 Nov 2009
A costing statement accompanying the NICE guidance on topotecan for relapsed small cell lung cancer (SCLC) notes that it is unlikely to result in a significant change in resource use in the NHS due to small patient numbers (an estimated ...
View Blog: NeLM - News - http://www.nelm.nhs.uk/en/NeLM-Area/News/

---

View Post: Flow Cytometric Detection of Small Cell Lung Cancer Cells with ...
2 Nov 2009 by Danbara, M., Yoshida, M., Kanoh, Y., Jiang,...  
Flow Cytometric Detection of Small Cell Lung Cancer Cells with Aberrant CD45 Expression in Micrometastatic Bone Marrow. Mikio Danbara1, Mitsugu Yoshida2, Yuhsaku Kanoh3, Shi-Xu Jiang4, Noriyuki Masuda5, Tohru Akahoshi6 and Masaaki ...
View Blog: Japanese Journal of Clinical Oncology -... - http://jjco.oxfordjournals.org/

---